Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation

SEE constituted 11.5% of clinically recognized thromboembolic events in patients with atrial fibrillation and was associated with high morbidity and mortality. SEE mortality was comparable to that of ischemic stroke and varied by anatomic site.